XML 25 R43.htm IDEA: XBRL DOCUMENT v2.4.0.8
Supplemental Guarantor Information (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Dec. 31, 2012
Condensed Consolidating Statements of Operations and Comprehensive Income          
Revenue $ 310.8 $ 368.2 $ 948.5 $ 1,099.2  
Operating costs and expenses 253.1 302.2 824.8 887.0  
Operating (loss) income 57.7 66.0 123.7 212.2  
Interest expense (income), net 46.7 55.2 140.0 163.3  
Other (income) expense, net (1.2) 0.1 (1.4) 1.6  
(Loss) income before equity in earnings of subsidiaries and income taxes 10.7 10.7 (23.0) 47.3  
Income tax (benefit) expense 1.4 6.8 3.6 26.3  
Net income (loss) 9.3 3.9 (26.6) 21.0  
Total comprehensive income 34.1 6.2 9.8 27.4  
Preferred stock dividends 2.6 2.6 7.8 7.8  
Net income (loss) applicable to common shareowners 6.7 1.3 (34.4) 13.2  
Condensed Consolidating Balance Sheets          
Cash and cash equivalents 413.7 7.7 413.7 7.7  
Other current assets 3.6   3.6   11.6
Total current assets 650.3   650.3   303.5
Property, plant and equipment, net 892.5   892.5   1,587.4
Investment in CyrusOne 480.7   480.7   0
Other noncurrent assets 44.1   44.1   86.3
Total assets 2,551.7   2,551.7   2,872.4
Current portion of long-term debt 508.9   508.9   13.4
Accounts payable 107.3   107.3   135.6
Other current liabilities 32.2   32.2   40.2
Total current liabilities 797.5   797.5   355.4
Long-term debt, less current portion 2,108.2   2,108.2   2,676.0
Other noncurrent liabilities 70.9   70.9   176.5
Total liabilities 3,238.9   3,238.9   3,570.6
Shareowners' (deficit) equity (687.2)   (687.2)   (698.2)
Total liabilities and shareowners' equity (deficit) 2,551.7   2,551.7   2,872.4
Condensed Consolidating Statements of Cash Flows          
Cash flows (used in) provided by operating activities     59.8 155.0  
Capital expenditures (46.1) (75.5) (142.0) (242.9)  
Dividends received from CyrusOne 7.2   14.2 0  
Proceeds from sale of assets     1.8 0.6  
Cash divested from deconsolidation of CyrusOne     (12.2) 0  
Cash flows used in investing activities     (137.8) (252.7)  
Issuance of long-term debt     536.0 0  
Debt issuance costs     (6.4) 0  
Borrowings on revolving facilities, net     (52.0) 44.0  
Repayment of debt     (6.7) (11.3)  
Common stock repurchase     0 (0.3)  
Proceeds from exercise of options and warrants     6.8 8.1  
Other financing activities     (2.3) (1.0)  
Cash flows provided by (used in) financing activities     468.1 31.7  
Increase (decrease) in cash and cash equivalents     390.1 (66.0)  
Cash and cash equivalents at beginning of period     23.6 73.7  
Cash and cash equivalents at end of period 413.7 7.7 413.7 7.7  
Notes guaranteed by subsidiaries [Member]
         
Condensed Consolidating Statements of Operations and Comprehensive Income          
Revenue 310.8 368.2 948.5 1,099.2  
Operating costs and expenses 253.1 302.2 824.8 887.0  
Operating (loss) income 57.7 66.0 123.7 212.2  
Interest expense (income), net 46.7 55.2 140.0 163.3  
Other (income) expense, net 0.3 0.1 6.7 1.6  
(Loss) income before equity in earnings of subsidiaries and income taxes 10.7 10.7 (23.0) 47.3  
Income tax (benefit) expense 1.4 6.8 3.6 26.3  
Equity in earnings of subsidiaries, net of tax 0 0 0 0  
Net income (loss) 9.3 3.9 (26.6) 21.0  
Other comprehensive income (loss) 24.8 2.3 36.4 6.4  
Total comprehensive income 34.1 6.2 9.8 27.4  
Preferred stock dividends 2.6 2.6 7.8 7.8  
Net income (loss) applicable to common shareowners 6.7 1.3 (34.4) 13.2  
Condensed Consolidating Balance Sheets          
Cash and cash equivalents 413.7 7.7 413.7 7.7  
Receivables, net 161.4   161.4   199.0
Other current assets 75.2   75.2   80.9
Total current assets 650.3   650.3   303.5
Property, plant and equipment, net 892.5   892.5   1,587.4
Investment in CyrusOne 480.7   480.7    
Goodwill and intangibles, net 107.2   107.2   487.4
Investments in and advances to subsidiaries 0   0   0
Other noncurrent assets 421.0   421.0   494.1
Total assets 2,551.7   2,551.7   2,872.4
Current portion of long-term debt 508.9   508.9   13.4
Accounts payable 108.3   108.3   135.6
Other current liabilities 180.3   180.3   206.4
Total current liabilities 797.5   797.5   355.4
Long-term debt, less current portion 2,108.2   2,108.2   2,676.0
Other noncurrent liabilities 333.2   333.2   539.2
Intercompany payables 0   0   0
Total liabilities 3,238.9   3,238.9   3,570.6
Shareowners' (deficit) equity (687.2)   (687.2)   (698.2)
Total liabilities and shareowners' equity (deficit) 2,551.7   2,551.7   2,872.4
Condensed Consolidating Statements of Cash Flows          
Cash flows (used in) provided by operating activities     59.8 155.0  
Capital expenditures     (142.0) (242.9)  
Dividends received from CyrusOne     14.2    
Proceeds from sale of assets     1.8 0.6  
Cash divested from deconsolidation of CyrusOne     (12.2)    
Other investing activities     0.4 (10.4)  
Cash flows used in investing activities     (137.8) (252.7)  
Issuance of long-term debt     536.0    
Funding between Parent and subsidiaries, net     0 0  
Debt issuance costs     (6.4)    
Borrowings on revolving facilities, net     (52.0) 44.0  
Repayment of debt     (6.7) (11.3)  
Common stock repurchase       (0.3)  
Proceeds from exercise of options and warrants     6.8 8.1  
Other financing activities     (9.6) (8.8)  
Cash flows provided by (used in) financing activities     468.1 31.7  
Increase (decrease) in cash and cash equivalents     390.1 (66.0)  
Cash and cash equivalents at beginning of period     23.6 73.7  
Cash and cash equivalents at end of period 413.7 7.7 413.7 7.7  
Notes guaranteed by subsidiaries [Member] | Parent Company [Member]
         
Condensed Consolidating Statements of Operations and Comprehensive Income          
Revenue 0 0 0 0  
Operating costs and expenses 1.5 12.5 51.2 23.6  
Operating (loss) income (1.5) (12.5) (51.2) (23.6)  
Interest expense (income), net 42.9 41.1 125.0 122.5  
Other (income) expense, net (0.4) (0.5) (1.1) (1.2)  
(Loss) income before equity in earnings of subsidiaries and income taxes (44.0) (53.1) (175.1) (144.9)  
Income tax (benefit) expense (18.5) (16.1) (59.8) (45.9)  
Equity in earnings of subsidiaries, net of tax 34.8 40.9 88.7 120.0  
Net income (loss) 9.3 3.9 (26.6) 21.0  
Other comprehensive income (loss) 24.8 2.2 36.5 6.3  
Total comprehensive income 34.1 6.1 9.9 27.3  
Preferred stock dividends 2.6 2.6 7.8 7.8  
Net income (loss) applicable to common shareowners 6.7 1.3 (34.4) 13.2  
Condensed Consolidating Balance Sheets          
Cash and cash equivalents 411.1 2.3 411.1 2.3  
Receivables, net 1.6   1.6   1.0
Other current assets 2.6   2.6   3.1
Total current assets 415.3   415.3   7.9
Property, plant and equipment, net 0.1   0.1   0.1
Investment in CyrusOne 0   0    
Goodwill and intangibles, net 0   0   0
Investments in and advances to subsidiaries 1,546.8   1,546.8   1,449.9
Other noncurrent assets 380.6   380.6   384.6
Total assets 2,342.8   2,342.8   1,842.5
Current portion of long-term debt 501.7   501.7   0
Accounts payable 1.0   1.0   1.2
Other current liabilities 93.3   93.3   85.6
Total current liabilities 596.0   596.0   86.8
Long-term debt, less current portion 1,877.2   1,877.2   1,841.7
Other noncurrent liabilities 274.3   274.3   383.3
Intercompany payables 282.5   282.5   228.9
Total liabilities 3,030.0   3,030.0   2,540.7
Shareowners' (deficit) equity (687.2)   (687.2)   (698.2)
Total liabilities and shareowners' equity (deficit) 2,342.8   2,342.8   1,842.5
Condensed Consolidating Statements of Cash Flows          
Cash flows (used in) provided by operating activities     (165.0) (69.1)  
Capital expenditures     0 0  
Dividends received from CyrusOne     0    
Proceeds from sale of assets     0 0  
Cash divested from deconsolidation of CyrusOne     0    
Other investing activities     0 0  
Cash flows used in investing activities     0 0  
Issuance of long-term debt     536.0    
Funding between Parent and subsidiaries, net     45.5 2.9  
Debt issuance costs     (6.4)    
Borrowings on revolving facilities, net     0 0  
Repayment of debt     0 0  
Common stock repurchase       (0.3)  
Proceeds from exercise of options and warrants     6.8 8.1  
Other financing activities     (9.6) (8.9)  
Cash flows provided by (used in) financing activities     572.3 1.8  
Increase (decrease) in cash and cash equivalents     407.3 (67.3)  
Cash and cash equivalents at beginning of period     3.8 69.6  
Cash and cash equivalents at end of period 411.1 2.3 411.1 2.3  
Notes guaranteed by subsidiaries [Member] | Guarantor Subsidiaries [Member]
         
Condensed Consolidating Statements of Operations and Comprehensive Income          
Revenue 177.4 176.6 530.7 530.5  
Operating costs and expenses 162.5 158.0 496.1 474.8  
Operating (loss) income 14.9 18.6 34.6 55.7  
Interest expense (income), net 3.5 1.8 11.2 5.6  
Other (income) expense, net 3.2 2.3 12.1 6.4  
(Loss) income before equity in earnings of subsidiaries and income taxes 8.2 14.5 11.3 43.7  
Income tax (benefit) expense 3.1 4.6 11.9 16.2  
Equity in earnings of subsidiaries, net of tax 0 3.5 0.7 (10.3)  
Net income (loss) 5.1 13.4 0.1 17.2  
Other comprehensive income (loss) 0 0 0 0  
Total comprehensive income 5.1 13.4 0.1 17.2  
Preferred stock dividends 0 0 0 0  
Net income (loss) applicable to common shareowners 5.1 13.4 0.1 17.2  
Condensed Consolidating Balance Sheets          
Cash and cash equivalents 0.5 0.7 0.5 0.7  
Receivables, net 7.2   7.2   1.2
Other current assets 39.9   39.9   27.7
Total current assets 47.6   47.6   29.2
Property, plant and equipment, net 196.0   196.0   220.9
Investment in CyrusOne 480.7   480.7    
Goodwill and intangibles, net 104.9   104.9   106.4
Investments in and advances to subsidiaries 340.3   340.3   506.4
Other noncurrent assets 190.6   190.6   218.5
Total assets 1,360.1   1,360.1   1,081.4
Current portion of long-term debt 3.0   3.0   3.9
Accounts payable 72.4   72.4   90.2
Other current liabilities 38.1   38.1   33.6
Total current liabilities 113.5   113.5   127.7
Long-term debt, less current portion 87.2   87.2   88.4
Other noncurrent liabilities 62.2   62.2   90.6
Intercompany payables 144.7   144.7   160.0
Total liabilities 407.6   407.6   466.7
Shareowners' (deficit) equity 952.5   952.5   614.7
Total liabilities and shareowners' equity (deficit) 1,360.1   1,360.1   1,081.4
Condensed Consolidating Statements of Cash Flows          
Cash flows (used in) provided by operating activities     27.4 47.1  
Capital expenditures     (25.6) (22.9)  
Dividends received from CyrusOne     14.2    
Proceeds from sale of assets     0 0.2  
Cash divested from deconsolidation of CyrusOne     0    
Other investing activities     0 0  
Cash flows used in investing activities     (11.4) (22.7)  
Issuance of long-term debt     0    
Funding between Parent and subsidiaries, net     (12.6) (21.0)  
Debt issuance costs     0    
Borrowings on revolving facilities, net     0 0  
Repayment of debt     (3.2) (3.5)  
Common stock repurchase       0  
Proceeds from exercise of options and warrants     0 0  
Other financing activities     0 0.1  
Cash flows provided by (used in) financing activities     (15.8) (24.4)  
Increase (decrease) in cash and cash equivalents     0.2 0  
Cash and cash equivalents at beginning of period     0.3 0.7  
Cash and cash equivalents at end of period 0.5 0.7 0.5 0.7  
Notes guaranteed by subsidiaries [Member] | Non-Guarantor Subsidiaries [Member]
         
Condensed Consolidating Statements of Operations and Comprehensive Income          
Revenue 147.5 207.0 460.0 615.1  
Operating costs and expenses 103.2 147.1 319.7 435.0  
Operating (loss) income 44.3 59.9 140.3 180.1  
Interest expense (income), net 0.3 12.3 3.8 35.2  
Other (income) expense, net (2.5) (1.7) (4.3) (3.6)  
(Loss) income before equity in earnings of subsidiaries and income taxes 46.5 49.3 140.8 148.5  
Income tax (benefit) expense 16.8 18.3 51.5 56.0  
Equity in earnings of subsidiaries, net of tax 0 0 0 0  
Net income (loss) 29.7 31.0 89.3 92.5  
Other comprehensive income (loss) 0 0.1 (0.1) 0.1  
Total comprehensive income 29.7 31.1 89.2 92.6  
Preferred stock dividends 0 0 0 0  
Net income (loss) applicable to common shareowners 29.7 31.0 89.3 92.5  
Condensed Consolidating Balance Sheets          
Cash and cash equivalents 2.1 4.7 2.1 4.7  
Receivables, net 152.6   152.6   196.8
Other current assets 33.1   33.1   50.5
Total current assets 187.8   187.8   266.8
Property, plant and equipment, net 696.4   696.4   1,366.4
Investment in CyrusOne 0   0    
Goodwill and intangibles, net 2.3   2.3   381.0
Investments in and advances to subsidiaries 260.7   260.7   192.5
Other noncurrent assets 5.1   5.1   54.1
Total assets 1,152.3   1,152.3   2,260.8
Current portion of long-term debt 4.2   4.2   9.5
Accounts payable 34.9   34.9   44.2
Other current liabilities 49.5   49.5   86.3
Total current liabilities 88.6   88.6   140.0
Long-term debt, less current portion 143.8   143.8   745.9
Other noncurrent liabilities 151.8   151.8   229.7
Intercompany payables 133.7   133.7   102.6
Total liabilities 517.9   517.9   1,218.2
Shareowners' (deficit) equity 634.4   634.4   1,042.6
Total liabilities and shareowners' equity (deficit) 1,152.3   1,152.3   2,260.8
Condensed Consolidating Statements of Cash Flows          
Cash flows (used in) provided by operating activities     197.4 177.0  
Capital expenditures     (116.4) (220.0)  
Dividends received from CyrusOne     0    
Proceeds from sale of assets     1.8 0.4  
Cash divested from deconsolidation of CyrusOne     (12.2)    
Other investing activities     0.4 (10.4)  
Cash flows used in investing activities     (126.4) (230.0)  
Issuance of long-term debt     0    
Funding between Parent and subsidiaries, net     (32.9) 18.1  
Debt issuance costs     0    
Borrowings on revolving facilities, net     (52.0) 44.0  
Repayment of debt     (3.5) (7.8)  
Common stock repurchase       0  
Proceeds from exercise of options and warrants     0 0  
Other financing activities     0 0  
Cash flows provided by (used in) financing activities     (88.4) 54.3  
Increase (decrease) in cash and cash equivalents     (17.4) 1.3  
Cash and cash equivalents at beginning of period     19.5 3.4  
Cash and cash equivalents at end of period 2.1 4.7 2.1 4.7  
Notes guaranteed by subsidiaries [Member] | Consolidation, Eliminations [Member]
         
Condensed Consolidating Statements of Operations and Comprehensive Income          
Revenue (14.1) (15.4) (42.2) (46.4)  
Operating costs and expenses (14.1) (15.4) (42.2) (46.4)  
Operating (loss) income 0 0 0 0  
Interest expense (income), net 0 0 0 0  
Other (income) expense, net 0 0 0 0  
(Loss) income before equity in earnings of subsidiaries and income taxes 0 0 0 0  
Income tax (benefit) expense 0 0 0 0  
Equity in earnings of subsidiaries, net of tax (34.8) (44.4) (89.4) (109.7)  
Net income (loss) (34.8) (44.4) (89.4) (109.7)  
Other comprehensive income (loss) 0 0 0 0  
Total comprehensive income (34.8) (44.4) (89.4) (109.7)  
Preferred stock dividends 0 0 0 0  
Net income (loss) applicable to common shareowners (34.8) (44.4) (89.4) (109.7)  
Condensed Consolidating Balance Sheets          
Cash and cash equivalents 0 0 0 0  
Receivables, net 0   0   0
Other current assets (0.4)   (0.4)   (0.4)
Total current assets (0.4)   (0.4)   (0.4)
Property, plant and equipment, net 0   0   0
Investment in CyrusOne 0   0    
Goodwill and intangibles, net 0   0   0
Investments in and advances to subsidiaries (2,147.8)   (2,147.8)   (2,148.8)
Other noncurrent assets (155.3)   (155.3)   (163.1)
Total assets (2,303.5)   (2,303.5)   (2,312.3)
Current portion of long-term debt 0   0   0
Accounts payable 0   0   0
Other current liabilities (0.6)   (0.6)   0.9
Total current liabilities (0.6)   (0.6)   0.9
Long-term debt, less current portion 0   0   0
Other noncurrent liabilities (155.1)   (155.1)   (164.4)
Intercompany payables (560.9)   (560.9)   (491.5)
Total liabilities (716.6)   (716.6)   (655.0)
Shareowners' (deficit) equity (1,586.9)   (1,586.9)   (1,657.3)
Total liabilities and shareowners' equity (deficit) (2,303.5)   (2,303.5)   (2,312.3)
Condensed Consolidating Statements of Cash Flows          
Cash flows (used in) provided by operating activities     0 0  
Capital expenditures     0 0  
Dividends received from CyrusOne     0    
Proceeds from sale of assets     0 0  
Cash divested from deconsolidation of CyrusOne     0    
Other investing activities     0 0  
Cash flows used in investing activities     0 0  
Issuance of long-term debt     0    
Funding between Parent and subsidiaries, net     0 0  
Debt issuance costs     0    
Borrowings on revolving facilities, net     0 0  
Repayment of debt     0 0  
Common stock repurchase       0  
Proceeds from exercise of options and warrants     0 0  
Other financing activities     0 0  
Cash flows provided by (used in) financing activities     0 0  
Increase (decrease) in cash and cash equivalents     0 0  
Cash and cash equivalents at beginning of period     0 0  
Cash and cash equivalents at end of period 0 0 0 0  
Notes guaranteed by parent [Member]
         
Condensed Consolidating Statements of Operations and Comprehensive Income          
Revenue 310.8 368.2 948.5 1,099.2  
Operating costs and expenses 253.1 302.2 824.8 887.0  
Operating (loss) income 57.7 66.0 123.7 212.2  
Interest expense (income), net 46.7 55.2 140.0 163.3  
Other (income) expense, net 0.3 0.1 6.7 1.6  
(Loss) income before equity in earnings of subsidiaries and income taxes 10.7 10.7 (23.0) 47.3  
Income tax (benefit) expense 1.4 6.8 3.6 26.3  
Equity in earnings of subsidiaries, net of tax 0 0 0 0  
Net income (loss) 9.3 3.9 (26.6) 21.0  
Other comprehensive income (loss) 24.8 2.3 36.4 6.4  
Total comprehensive income 34.1 6.2 9.8 27.4  
Preferred stock dividends 2.6 2.6 7.8 7.8  
Net income (loss) applicable to common shareowners 6.7 1.3 (34.4) 13.2  
Condensed Consolidating Balance Sheets          
Cash and cash equivalents 413.7 7.7 413.7 7.7  
Receivables, net 161.4   161.4   199.0
Other current assets 75.2   75.2   80.9
Total current assets 650.3   650.3   303.5
Property, plant and equipment, net 892.5   892.5   1,587.4
Investment in CyrusOne 480.7   480.7    
Goodwill and intangibles, net 107.2   107.2   487.4
Investments in and advances to subsidiaries 0   0   0
Other noncurrent assets 421.0   421.0   494.1
Total assets 2,551.7   2,551.7   2,872.4
Current portion of long-term debt 508.9   508.9   13.4
Accounts payable 108.3   108.3   135.6
Other current liabilities 180.3   180.3   206.4
Total current liabilities 797.5   797.5   355.4
Long-term debt, less current portion 2,108.2   2,108.2   2,676.0
Other noncurrent liabilities 333.2   333.2   539.2
Intercompany payables 0   0   0
Total liabilities 3,238.9   3,238.9   3,570.6
Shareowners' (deficit) equity (687.2)   (687.2)   (698.2)
Total liabilities and shareowners' equity (deficit) 2,551.7   2,551.7   2,872.4
Condensed Consolidating Statements of Cash Flows          
Cash flows (used in) provided by operating activities     59.8 155.0  
Capital expenditures     (142.0) (242.9)  
Dividends received from CyrusOne     14.2    
Proceeds from sale of assets     1.8 0.6  
Cash divested from deconsolidation of CyrusOne     (12.2)    
Other investing activities     0.4 (10.4)  
Cash flows used in investing activities     (137.8) (252.7)  
Issuance of long-term debt     536.0    
Funding between Parent and subsidiaries, net     0 0  
Debt issuance costs     (6.4)    
Borrowings on revolving facilities, net     (52.0) 44.0  
Repayment of debt     (6.7) (11.3)  
Common stock repurchase       (0.3)  
Proceeds from exercise of options and warrants     6.8 8.1  
Other financing activities     (9.6) (8.8)  
Cash flows provided by (used in) financing activities     468.1 31.7  
Increase (decrease) in cash and cash equivalents     390.1 (66.0)  
Cash and cash equivalents at beginning of period     23.6 73.7  
Cash and cash equivalents at end of period 413.7 7.7 413.7 7.7  
Notes guaranteed by parent [Member] | Parent Company [Member]
         
Condensed Consolidating Statements of Operations and Comprehensive Income          
Revenue 0 0 0 0  
Operating costs and expenses 1.5 12.5 51.2 23.6  
Operating (loss) income (1.5) (12.5) (51.2) (23.6)  
Interest expense (income), net 42.9 41.1 125.0 122.5  
Other (income) expense, net (0.4) (0.5) (1.1) (1.2)  
(Loss) income before equity in earnings of subsidiaries and income taxes (44.0) (53.1) (175.1) (144.9)  
Income tax (benefit) expense (18.5) (16.1) (59.8) (45.9)  
Equity in earnings of subsidiaries, net of tax 34.8 40.9 88.7 120.0  
Net income (loss) 9.3 3.9 (26.6) 21.0  
Other comprehensive income (loss) 24.8 2.2 36.5 6.3  
Total comprehensive income 34.1 6.1 9.9 27.3  
Preferred stock dividends 2.6 2.6 7.8 7.8  
Net income (loss) applicable to common shareowners 6.7 1.3 (34.4) 13.2  
Condensed Consolidating Balance Sheets          
Cash and cash equivalents 411.1 2.3 411.1 2.3  
Receivables, net 1.6   1.6   1.0
Other current assets 2.6   2.6   3.1
Total current assets 415.3   415.3   7.9
Property, plant and equipment, net 0.1   0.1   0.1
Investment in CyrusOne 0   0    
Goodwill and intangibles, net 0   0   0
Investments in and advances to subsidiaries 1,546.8   1,546.8   1,449.9
Other noncurrent assets 380.6   380.6   384.6
Total assets 2,342.8   2,342.8   1,842.5
Current portion of long-term debt 501.7   501.7   0
Accounts payable 1.0   1.0   1.2
Other current liabilities 93.3   93.3   85.6
Total current liabilities 596.0   596.0   86.8
Long-term debt, less current portion 1,877.2   1,877.2   1,841.7
Other noncurrent liabilities 274.3   274.3   383.3
Intercompany payables 282.5   282.5   228.9
Total liabilities 3,030.0   3,030.0   2,540.7
Shareowners' (deficit) equity (687.2)   (687.2)   (698.2)
Total liabilities and shareowners' equity (deficit) 2,342.8   2,342.8   1,842.5
Condensed Consolidating Statements of Cash Flows          
Cash flows (used in) provided by operating activities     (165.0) (69.1)  
Capital expenditures     0 0  
Dividends received from CyrusOne     0    
Proceeds from sale of assets     0 0  
Cash divested from deconsolidation of CyrusOne     0    
Other investing activities     0 0  
Cash flows used in investing activities     0 0  
Issuance of long-term debt     536.0    
Funding between Parent and subsidiaries, net     45.5 2.9  
Debt issuance costs     (6.4)    
Borrowings on revolving facilities, net     0 0  
Repayment of debt     0 0  
Common stock repurchase       (0.3)  
Proceeds from exercise of options and warrants     6.8 8.1  
Other financing activities     (9.6) (8.9)  
Cash flows provided by (used in) financing activities     572.3 1.8  
Increase (decrease) in cash and cash equivalents     407.3 (67.3)  
Cash and cash equivalents at beginning of period     3.8 69.6  
Cash and cash equivalents at end of period 411.1 2.3 411.1 2.3  
Notes guaranteed by parent [Member] | Cincinnati Bell Telephone Company [Member]
         
Condensed Consolidating Statements of Operations and Comprehensive Income          
Revenue 161.4 160.8 482.3 482.0  
Operating costs and expenses 115.3 112.0 340.0 324.8  
Operating (loss) income 46.1 48.8 142.3 157.2  
Interest expense (income), net (0.3) (0.6) (1.4) (0.8)  
Other (income) expense, net 1.8 0.6 4.4 2.9  
(Loss) income before equity in earnings of subsidiaries and income taxes 44.6 48.8 139.3 155.1  
Income tax (benefit) expense 16.4 18.1 51.2 56.6  
Equity in earnings of subsidiaries, net of tax 0 0 0 0  
Net income (loss) 28.2 30.7 88.1 98.5  
Other comprehensive income (loss) 0 0 0 0  
Total comprehensive income 28.2 30.7 88.1 98.5  
Preferred stock dividends 0 0 0 0  
Net income (loss) applicable to common shareowners 28.2 30.7 88.1 98.5  
Condensed Consolidating Balance Sheets          
Cash and cash equivalents 2.0 1.3 2.0 1.3  
Receivables, net 0   0   0
Other current assets 29.3   29.3   34.4
Total current assets 31.3   31.3   36.3
Property, plant and equipment, net 694.2   694.2   646.7
Investment in CyrusOne 0   0    
Goodwill and intangibles, net 2.3   2.3   2.3
Investments in and advances to subsidiaries 288.8   288.8   228.2
Other noncurrent assets 6.2   6.2   6.3
Total assets 1,022.8   1,022.8   919.8
Current portion of long-term debt 3.9   3.9   3.0
Accounts payable 58.7   58.7   61.7
Other current liabilities 50.8   50.8   50.2
Total current liabilities 113.4   113.4   114.9
Long-term debt, less current portion 142.3   142.3   141.3
Other noncurrent liabilities 153.9   153.9   138.6
Intercompany payables 0   0   0
Total liabilities 409.6   409.6   394.8
Shareowners' (deficit) equity 613.2   613.2   525.0
Total liabilities and shareowners' equity (deficit) 1,022.8   1,022.8   919.8
Condensed Consolidating Statements of Cash Flows          
Cash flows (used in) provided by operating activities     170.1 169.7  
Capital expenditures     (108.7) (73.6)  
Dividends received from CyrusOne     0    
Proceeds from sale of assets     1.8 0.4  
Cash divested from deconsolidation of CyrusOne     0    
Other investing activities     0 0  
Cash flows used in investing activities     (106.9) (73.2)  
Issuance of long-term debt     0    
Funding between Parent and subsidiaries, net     (60.5) (94.3)  
Debt issuance costs     0    
Borrowings on revolving facilities, net     0 0  
Repayment of debt     (2.6) (2.3)  
Common stock repurchase       0  
Proceeds from exercise of options and warrants     0 0  
Other financing activities     0 0  
Cash flows provided by (used in) financing activities     (63.1) (96.6)  
Increase (decrease) in cash and cash equivalents     0.1 (0.1)  
Cash and cash equivalents at beginning of period     1.9 1.4  
Cash and cash equivalents at end of period 2.0 1.3 2.0 1.3  
Notes guaranteed by parent [Member] | Non-Guarantor Subsidiaries [Member]
         
Condensed Consolidating Statements of Operations and Comprehensive Income          
Revenue 163.5 222.8 508.4 663.6  
Operating costs and expenses 150.4 193.1 475.8 585.0  
Operating (loss) income 13.1 29.7 32.6 78.6  
Interest expense (income), net 4.1 14.7 16.4 41.6  
Other (income) expense, net (1.1) 0 3.4 (0.1)  
(Loss) income before equity in earnings of subsidiaries and income taxes 10.1 15.0 12.8 37.1  
Income tax (benefit) expense 3.5 4.8 12.2 15.6  
Equity in earnings of subsidiaries, net of tax 0 0 0 0  
Net income (loss) 6.6 10.2 0.6 21.5  
Other comprehensive income (loss) 0 0.1 (0.1) 0.1  
Total comprehensive income 6.6 10.3 0.5 21.6  
Preferred stock dividends 0 0 0 0  
Net income (loss) applicable to common shareowners 6.6 10.2 0.6 21.5  
Condensed Consolidating Balance Sheets          
Cash and cash equivalents 0.6 4.1 0.6 4.1  
Receivables, net 159.8   159.8   198.0
Other current assets 43.7   43.7   43.8
Total current assets 204.1   204.1   259.7
Property, plant and equipment, net 198.2   198.2   940.6
Investment in CyrusOne 480.7   480.7    
Goodwill and intangibles, net 104.9   104.9   485.1
Investments in and advances to subsidiaries 0   0   0
Other noncurrent assets 189.5   189.5   266.3
Total assets 1,177.4   1,177.4   1,951.7
Current portion of long-term debt 3.3   3.3   10.4
Accounts payable 48.6   48.6   72.7
Other current liabilities 36.8   36.8   69.7
Total current liabilities 88.7   88.7   152.8
Long-term debt, less current portion 88.7   88.7   693.0
Other noncurrent liabilities 60.1   60.1   181.7
Intercompany payables 292.7   292.7   276.4
Total liabilities 530.2   530.2   1,303.9
Shareowners' (deficit) equity 647.2   647.2   647.8
Total liabilities and shareowners' equity (deficit) 1,177.4   1,177.4   1,951.7
Condensed Consolidating Statements of Cash Flows          
Cash flows (used in) provided by operating activities     54.7 54.4  
Capital expenditures     (33.3) (169.3)  
Dividends received from CyrusOne     14.2    
Proceeds from sale of assets     0 0.2  
Cash divested from deconsolidation of CyrusOne     (12.2)    
Other investing activities     0.4 (10.4)  
Cash flows used in investing activities     (30.9) (179.5)  
Issuance of long-term debt     0    
Funding between Parent and subsidiaries, net     15.0 91.4  
Debt issuance costs     0    
Borrowings on revolving facilities, net     (52.0) 44.0  
Repayment of debt     (4.1) (9.0)  
Common stock repurchase       0  
Proceeds from exercise of options and warrants     0 0  
Other financing activities     0 0.1  
Cash flows provided by (used in) financing activities     (41.1) 126.5  
Increase (decrease) in cash and cash equivalents     (17.3) 1.4  
Cash and cash equivalents at beginning of period     17.9 2.7  
Cash and cash equivalents at end of period 0.6 4.1 0.6 4.1  
Notes guaranteed by parent [Member] | Consolidation, Eliminations [Member]
         
Condensed Consolidating Statements of Operations and Comprehensive Income          
Revenue (14.1) (15.4) (42.2) (46.4)  
Operating costs and expenses (14.1) (15.4) (42.2) (46.4)  
Operating (loss) income 0 0 0 0  
Interest expense (income), net 0 0 0 0  
Other (income) expense, net 0 0 0 0  
(Loss) income before equity in earnings of subsidiaries and income taxes 0 0 0 0  
Income tax (benefit) expense 0 0 0 0  
Equity in earnings of subsidiaries, net of tax (34.8) (40.9) (88.7) (120.0)  
Net income (loss) (34.8) (40.9) (88.7) (120.0)  
Other comprehensive income (loss) 0 0 0 0  
Total comprehensive income (34.8) (40.9) (88.7) (120.0)  
Preferred stock dividends 0 0 0 0  
Net income (loss) applicable to common shareowners (34.8) (40.9) (88.7) (120.0)  
Condensed Consolidating Balance Sheets          
Cash and cash equivalents 0 0 0 0  
Receivables, net 0   0   0
Other current assets (0.4)   (0.4)   (0.4)
Total current assets (0.4)   (0.4)   (0.4)
Property, plant and equipment, net 0   0   0
Investment in CyrusOne 0   0    
Goodwill and intangibles, net 0   0   0
Investments in and advances to subsidiaries (1,835.6)   (1,835.6)   (1,678.1)
Other noncurrent assets (155.3)   (155.3)   (163.1)
Total assets (1,991.3)   (1,991.3)   (1,841.6)
Current portion of long-term debt 0   0   0
Accounts payable 0   0   0
Other current liabilities (0.6)   (0.6)   0.9
Total current liabilities (0.6)   (0.6)   0.9
Long-term debt, less current portion 0   0   0
Other noncurrent liabilities (155.1)   (155.1)   (164.4)
Intercompany payables (575.2)   (575.2)   (505.3)
Total liabilities (730.9)   (730.9)   (668.8)
Shareowners' (deficit) equity (1,260.4)   (1,260.4)   (1,172.8)
Total liabilities and shareowners' equity (deficit) (1,991.3)   (1,991.3)   (1,841.6)
Condensed Consolidating Statements of Cash Flows          
Cash flows (used in) provided by operating activities     0 0  
Capital expenditures     0 0  
Dividends received from CyrusOne     0    
Proceeds from sale of assets     0 0  
Cash divested from deconsolidation of CyrusOne     0    
Other investing activities     0 0  
Cash flows used in investing activities     0 0  
Issuance of long-term debt     0    
Funding between Parent and subsidiaries, net     0 0  
Debt issuance costs     0    
Borrowings on revolving facilities, net     0 0  
Repayment of debt     0 0  
Common stock repurchase       0  
Proceeds from exercise of options and warrants     0 0  
Other financing activities     0 0  
Cash flows provided by (used in) financing activities     0 0  
Increase (decrease) in cash and cash equivalents     0 0  
Cash and cash equivalents at beginning of period     0 0  
Cash and cash equivalents at end of period 0 0 0 0  
Various Cincinnati Bell Telephone notes [Member]
         
Debt Instruments [Abstract]          
Cincinnati Bell Telephone Notes Outstanding $ 134.5   $ 134.5   $ 134.5